IBS Treatment Market to Witness Robust Expansion by 2013-2025 - QY Research, Inc.

This report studies the IBS Treatment market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.

Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of IBS Treatment in these regions, from 2013 to 2025, covering

    North America (United States, Canada and Mexico)

    Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

    Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

    South America (Brazil etc.)

    Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

    Allergan Plc (Ireland)

    Sucampo Pharmaceuticals (U.S.)

    Ironwood Pharmaceuticals, Inc. (U.S.)

    Astellas Pharma Inc. (Japan)

    Valeant Pharmaceuticals (Canada)

    Abbott Laboratories (U.S.)

    Synergy Pharmaceuticals, Inc. (U.S.)

    Ardelyx, Inc. (U.S.)

    Nestle (Switzerland)

    Sebela Pharmaceuticals (Ireland)

    Probi (Sweden)

    Alfasigma USA, Inc. (Italy)

    RedHill Biopharma Ltd. (Israel)

    AstraZeneca (U.K)

    Ipsen (France)

    Novartis AG (Switzerland)

    Takeda Pharmaceutical Company Ltd (Japan)

    Synthetic Biologics, Inc. (U.S.)

    Protagonist Therapeutics Inc. (U.S.)

    Pfizer Inc (U.S.)

    Lexicon Pharmaceuticals, Inc. (U.S.)

    Innovate Biopharmaceuticals (U.S.)

By the product type, the market is primarily split into

    IBS-D

    IBS-C

    IBS-M

By the end users/application, this report covers the following segments

    Hospitals

    Clinics

    Research Laboratories

The study objectives of this report are:

    To study and analyze the global IBS Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

    To understand the structure of IBS Treatment market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global IBS Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the IBS Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of IBS Treatment submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

Request Sample Report and TOC@ http://www.qyresearchglobal.com/goods-1796027.html

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

QY Research Achievements:  

Year of Experience: 11 Years

Consulting Projects: 500+ successfully conducted so far

Global Reports: 5000 Reports Every Years

Resellers Partners for Our Reports: 150 + Across Globe

Global Clients: 34000+

Contact US

QY Research, INC.

Tina

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 295 2442

Email: sales@qyrsearchglobal.com

Web: www.qyresearchglobal.com

For other region, contact number given below

+86 108 294 5717 Beijing

+852 3062 8839 HK

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Room 2901 VILI International Building No.167 Linhe West Road

This release was published on openPR.